These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 34916494)

  • 1. Structure-guided bifunctional molecules hit a DEUBAD-lacking hRpn13 species upregulated in multiple myeloma.
    Lu X; Sabbasani VR; Osei-Amponsa V; Evans CN; King JC; Tarasov SG; Dyba M; Das S; Chan KC; Schwieters CD; Choudhari S; Fromont C; Zhao Y; Tran B; Chen X; Matsuo H; Andresson T; Chari R; Swenson RE; Tarasova NI; Walters KJ
    Nat Commun; 2021 Dec; 12(1):7318. PubMed ID: 34916494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Losing hRpn13 Pru or UCHL5 on Proteasome Clearance of Ubiquitinated Proteins and RA190 Cytotoxicity.
    Osei-Amponsa V; Sridharan V; Tandon M; Evans CN; Klarmann K; Cheng KT; Lack J; Chari R; Walters KJ
    Mol Cell Biol; 2020 Aug; 40(18):. PubMed ID: 32631902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A structure-based designed small molecule depletes hRpn13
    Lu X; Chandravanshi M; Sabbasani VR; Gaikwad S; Hughitt VK; Gyabaah-Kessie N; Scroggins BT; Das S; Myint W; Clapp ME; Schwieters CD; Dyba MA; Bolhuis DL; Koscielniak JW; Andresson T; Emanuele MJ; Brown NG; Matsuo H; Chari R; Citrin DE; Mock BA; Swenson RE; Walters KJ
    Nat Commun; 2024 Mar; 15(1):2485. PubMed ID: 38509117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. hRpn13 shapes the proteome and transcriptome through epigenetic factors HDAC8, PADI4, and transcription factor NF-κB p50.
    Osei-Amponsa V; Chandravanshi M; Lu X; Magidson V; Das S; Andresson T; Dyba M; Sabbasani VR; Swenson RE; Fromont C; Shrestha B; Zhao Y; Clapp ME; Chari R; Walters KJ
    Mol Cell; 2024 Feb; 84(3):522-537.e8. PubMed ID: 38151017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure of the Rpn13-Rpn2 complex provides insights for Rpn13 and Uch37 as anticancer targets.
    Lu X; Nowicka U; Sridharan V; Liu F; Randles L; Hymel D; Dyba M; Tarasov SG; Tarasova NI; Zhao XZ; Hamazaki J; Murata S; Burke TR; Walters KJ
    Nat Commun; 2017 Jun; 8():15540. PubMed ID: 28598414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An Extended Conformation for K48 Ubiquitin Chains Revealed by the hRpn2:Rpn13:K48-Diubiquitin Structure.
    Lu X; Ebelle DL; Matsuo H; Walters KJ
    Structure; 2020 May; 28(5):495-506.e3. PubMed ID: 32160516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A High Affinity hRpn2-Derived Peptide That Displaces Human Rpn13 from Proteasome in 293T Cells.
    Lu X; Liu F; Durham SE; Tarasov SG; Walters KJ
    PLoS One; 2015; 10(10):e0140518. PubMed ID: 26466095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Proteasome Ubiquitin Receptor hRpn13 and Its Interacting Deubiquitinating Enzyme Uch37 Are Required for Proper Cell Cycle Progression.
    Randles L; Anchoori RK; Roden RB; Walters KJ
    J Biol Chem; 2016 Apr; 291(16):8773-83. PubMed ID: 26907685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel proteasome interacting protein recruits the deubiquitinating enzyme UCH37 to 26S proteasomes.
    Hamazaki J; Iemura S; Natsume T; Yashiroda H; Tanaka K; Murata S
    EMBO J; 2006 Oct; 25(19):4524-36. PubMed ID: 16990800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. hRpn13/ADRM1/GP110 is a novel proteasome subunit that binds the deubiquitinating enzyme, UCH37.
    Qiu XB; Ouyang SY; Li CJ; Miao S; Wang L; Goldberg AL
    EMBO J; 2006 Dec; 25(24):5742-53. PubMed ID: 17139257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure of proteasome ubiquitin receptor hRpn13 and its activation by the scaffolding protein hRpn2.
    Chen X; Lee BH; Finley D; Walters KJ
    Mol Cell; 2010 May; 38(3):404-15. PubMed ID: 20471946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. hRpn13, a newly identified component of the 19S particle, regulates proliferation, differentiation, and function in the human osteoblast-like cell line MG63. [corrected].
    Zhao X; Chao Y; Chen P; Liu D; Su P; Sun J; Cui X; Tang Y
    J Physiol Biochem; 2012 Mar; 68(1):129-39. PubMed ID: 22057889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of novel anti-tumor therapeutic target via proteomic characterization of ubiquitin receptor ADRM1/Rpn13.
    Song Y; Du T; Ray A; Chauhan K; Samur M; Munshi N; Chauhan D; Anderson KC
    Blood Cancer J; 2021 Jan; 11(1):13. PubMed ID: 33441535
    [No Abstract]   [Full Text] [Related]  

  • 14. Proteolysis targeting chimeras (PROTACs) are emerging therapeutics for hematologic malignancies.
    He Y; Khan S; Huo Z; Lv D; Zhang X; Liu X; Yuan Y; Hromas R; Xu M; Zheng G; Zhou D
    J Hematol Oncol; 2020 Jul; 13(1):103. PubMed ID: 32718354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structures of Rpn1 T1:Rad23 and hRpn13:hPLIC2 Reveal Distinct Binding Mechanisms between Substrate Receptors and Shuttle Factors of the Proteasome.
    Chen X; Randles L; Shi K; Tarasov SG; Aihara H; Walters KJ
    Structure; 2016 Aug; 24(8):1257-1270. PubMed ID: 27396824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional differences between two major ubiquitin receptors in the proteasome; S5a and hRpn13.
    Elangovan M; Oh C; Sukumaran L; Wójcik C; Yoo YJ
    Biochem Biophys Res Commun; 2010 May; 396(2):425-8. PubMed ID: 20417181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphorylation of Tyr-950 in the proteasome scaffolding protein RPN2 modulates its interaction with the ubiquitin receptor RPN13.
    Hemmis CW; Heard SC; Hill CP
    J Biol Chem; 2019 Jun; 294(25):9659-9665. PubMed ID: 31064842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Induced degradation of proteins by PROTACs and other strategies: towards promising drugs].
    Reboud-Ravaux M
    Biol Aujourdhui; 2021; 215(1-2):25-43. PubMed ID: 34397373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteolysis-targeting chimeras (PROTACs) in cancer therapy.
    Li X; Pu W; Zheng Q; Ai M; Chen S; Peng Y
    Mol Cancer; 2022 Apr; 21(1):99. PubMed ID: 35410300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PROTACs: Novel approach for cancer breakdown by breaking proteins.
    Memon H; Patel BM
    Life Sci; 2022 Jul; 300():120577. PubMed ID: 35487303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.